References
1. Demirjian S., Lane B.R., Derweesh I.H., Takagi T., Fergany A., Campbell S.C. Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival. J Urol. 2014; 192: 1057–62.
2. Lane B.R., Demirjian S., Derweesh I.H., et al. Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular fi ltration rate. Eur Urol. 2015; 68: 996–1003.
3. Mir M.C., Campbell R.A., Sharma N., et al. Parenchymal volume preservation аnd ischemia during partial nephrectomy: functional and volumetric analysis. Urology. 2013; 82: 263–8.
4. Volpe A., Blute M.L., Ficarra V., et al. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol. 2015; 68: 61–74.
5. Ginzburg S., Uzzo R., Walton J., et al. Residual parenchymal volume, not warm ischemia time, predicts ultimate renal functional outcomes in patients undergoing partial nephrectomy. Urology. 2015; 86: 300–5.
6. Mir M.C., Ercole C., Takagi T., et al. Decline in renal function after partial nephrectomy: etiology and prevention. J Urol. 2015; 193: 1889–98.
7. Zhang Z., Zhao J., Dong W., et al. Acute kidney injury after partial nephrectomy: role of parenchymal mass reduction and ischemia and impact on subsequent functional recovery. Eur Urol. 2016; 69: 745–52.
8. Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001; 166: 6-18.
9. Russo P. Open partial nephrectomy: personal technique and current outcomes. Arch Esp Urol. 2011; 64: 571-93.
10. Kaouk J.H., Khalifeh A., Hillyer S., Haber G.P., Stein R.J., Autorino R. Robot-assisted laparoscopic partial nephrectomy: step-by-step contemporary technique and surgical outcomes at a single high-volume institution. Eur Urol. 2012; 62: 553-61.
11. Dong W., Zhang Z., Zhao J., et al. Excised parenchymal mass during partial nephrectomy: functional implications. Urology. 2017; 103: 129-35.
12. Bahler C.D., Dube H.T., Flynn K.J., et al. Feasibility of omitting cortical renorrhaphy during robot-assisted partial nephrectomy: a matched analysis. J Endourol. 2015; 29: 548-55.
13. Gupta G.N., Boris R.S., Campbell S.C., Zhang Z. Tumor enucleation for sporadic localized kidney cancer: pro and con. J Urol. 2015; 194: 623-5.
14. Blackwell R.H., Li B., Kozel Z., et al. Functional implications of renal tumor enucleation relative to standard partial nephrectomy. Urology. 2017; 99: 162-8.
15. Carini M., Minvervini A., Masieri L., Lapini A., Ser-ni S. Simple enucleation for the treatment of pT1a renal cell carcinoma: our 20 year experience. Eur Urol. 2006; 50: 1269-71.
16. Mukkamala A., Allam C.L., Ellison J.S., et al. Tumor enucleationvs sharp excision in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes. Urology. 2014; 83: 1294-9.
17. Longo N., Minervini A., Antonelli A., et al. Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). Eur J Surg Oncol. 2014; 40: 762-8.
18. Dong W., Lin T., Li F., et al. Laparoscopic partial nephrectomy for T1 renal cell carcinoma: comparison of two resection techniques in a multi-institutional propensity score-matching analysis. Ann Surg Oncol. 2016; 23: 1395-402.
19. Minervini A., di Cristofano C., Lapini A., et al. Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma. Eur Urol. 2014; 55: 1410-8.
20. Schiavina R., Serni S., Mari A., et al. A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian project. Clin Genitourin Cancer. 2015; 13: 165-70.
21. Garcia A.G., Leon T.G. Simple enucleation for renal tumors: indications, techniques, and results. Curr Urol Rep. 2016; 17: 7.
22. Minervini A., Campi R., Sessa F., et al. Positive surgical margins and local recurrence after simple enucleation and standard partial nephrectomy for malignant renal tumors: systematic review of the literature and meta-analysis of prevalence. Minerva Urol Nefrol. 2017; 69 (6): 523-38. DOI: http://doi.org/10.23736/S0393-2249.17.02864-8
23. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med. 1999; 130: 461-70.
24. Levin A., Stevens P.E. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014; 85: 49-61.
25. Campbell S.C., Uzzo R.G., Allaf M.E., et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017; 198 (3): 520-9. URL: http://doi.org/10.1016/j.juro.2017.04.100
26. Ljungberg B., Bensalah K., Bex A., et al. EAU guidelines on renal cell carcinoma. European Association of Urology, 2016. URL: https://uroweb.org/wp-content/uploads/EAU-Guidelines-Renal-Cell-Carcinoma-2016.pdf
27. Minervini A., Carini M., Uzzo R.G., Campi R., Smaldone M.C., Kutikov A. Standardized reporting of resection technique during nephronsparing surgery: the surface-intermediate-base margin score. Eur Urol. 2014; 66: 803-5.
28. Maurice M.J., Ramirez D., Malkop E., et al. Predictors of excisional volume loss in partial nephrectomy: Is there still room for improvement? Eur Urol. 2016; 70: 413-5.
29. Dong W., Wu J., Suk-Ouichai C., et al. Devascu-larized parenchymal mass associated with partial nephrectomy: predictive factors and impact on functional recovery. J Urol. 2017; 198 (4): 787-94. DOI: http://doi.org/10.1016/j.juro.2017.04.020
30. Satkunasivam R., Tsai S., Syan S., et al. Robotic unclamped «minimal-margin» partial nephrectomy: ongoing refinement of the anatomic zero-ischemia concept. Eur Urol. 2015; 68: 705-12.
31. Cheng X., He J., Gan W., Fan X., Yang J., Zhu B., et al. Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation? Int J Clin Exp Pathol. 2015; 8 (5): 5403-10.
32. Nguyen K.A., Syed J.S., Espenschied C.R., La-Duca H., Bhagat A.M., et al. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test. Cancer. 2017; 123 (22): 4363-71.